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Summary 
Murine T cell reactivity with products of the minor lymphocyte stimulatory (Mls) locus correlates 
with the expression of particular variable (V) domains of the T cell receptor (TCR) B chain. 
It was recently demonstrated that Mls antigens are encoded by an open reading frame (ORF) 
in the 3' long terminal repeat of either endogenous orexogenous mouse mammary tumor virus 
(MMTV). Immature thymocytes xpressing reactive TCR-Vo domains are clonally deleted upon 
exposure to endogenous Mtv's. Mature T cells proliferate vigorously in response to Mls-1 ~ 
(Mtv-7) in vivo, but induction of specific anergy and deletion after exposure to Mtv-7-expressing 
cells in the periphery has also been described. We show here that B cells and CD8 + (but not 
CD4 +) T cells from Mtv-7 + mice efficiently induce peripheral deletion of reactive T ceUs upon 
transfer to Mtv-7- recipients, whereas only B cells stimulate specific T cell proliferation i vivo. 
In contrast to endogenous Mtv-7, transfer of B, CD4 +, or CD8 + lymphocyte subsets from mice 
maternally infected with MMTV(SW), an infectious homologue of Mtv-7, results in specific 
T cell deletion in the absence of a detectable proliferative response. Finally, we show by secondary 
transfers of infected cells that exogenous MMTV(SW) is transmitted multidirectionally between 
lymphocyte subsets and ultimately to the mammary gland. Collectively our data demonstrate 
heterogeneity in the expression and/or presentation f endogenous and exogenous MMTV ORF 
by lymphocyte subsets and emphasize the low threshold required for induction of peripheral 
T cell deletion by these gene products. 
T cell reactivity to antigens of the Mls locus correlates 
with expression of certain TCK-Ve domains (1-5). The 
Mls loci have recently been shown to be encoded by open 
reading frames (ORF) 1 in the 3' long terminal repeat of 
different mouse mammary tumor viruses (MMTV) (6-8). 
Expression of Mw-7, an endogenous proviral MMTV locus 
that determines the Mls-P phenotype (9), leads to the in- 
trathymic deletion of cells expressing TCR-V~6, 7; 8.1, 
or 9 (1-5). Recently, we characterized an infectious equiva- 
lent of Mtv-7, called MMTV(SW) (10), that exhibits the 
same TCR-V0 specificity. MMTV(SW) and MW-70RF 
molecules are almost identical in their carboxy termini, apoly- 
morphic region that has been implicated in determining 
TCR-V0 specificity (11). The availability of MMTV(SW) 
1 Abbreviations u ed in this paper: MMTV, mouse mammary tumor virus; 
ORF, open reading frame. 
thus provides a unique opportunity to compare T cell re- 
sponses to endogenous and exogenous MMTV ORF products. 
In contrast to immature thymocytes, mature T cells re- 
spond by proliferation upon exposure to MMTV ORF prod- 
ucts. In the case of Mtv-7, this initial response is followed 
paradoxically by functional inactivation (anergy) and even, 
in some cases, by donal deletion of the reactive T cells (12-17). 
Very little is known about the mechanisms leading to pe- 
ripheral anergy and deletion of Mtv-7-reactive T cells, and 
it is still unclear whether these are causally related phenomena. 
Even less is known about exogenous MMTV, although there 
is evidence that lymphocytes may be involved in its transmis- 
sion to the mammary gland (18). 
In an attempt to clarify some of these issues, we have in- 
jected highly purified lymphocyte subsets (B, CD8 +, or 
CD4 + cells) from mice carrying the endogenous Mtv-7 or 
the exogenous MMTV(SW), into normal recipients and moni- 
tored their ability to elicit clonal expansion or deletion of 
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the reactive T ceils. Furthermore, we have used secondary 
transfer experiments oinvestigate he ability of these subsets 
to infect each other and ultimately lead to maternal trans- 
mission of the virus. 
Materials and Methods 
Mice. BALB/c, CBA/J, and CBA/Ca mice were obtained from 
Harlan Olac Ltd. (Bicester, UK) and BALB.D2.MIs-I' mice were 
maintained from breeding pairs originally provided by Dr. H. Festen- 
stein (London Hospital Medical College, London, UK) (19). Mice 
that were maternally infected with MMTV(SW) (BALB/c [SW]) 
were originally obtained from IFFA Credo (L'Arbresle, France) 
and subsequently maintained inour colony. For thymectomy, mice 
(5-6 wk of age) were anesthetised byintraperitoneal injection of 
600 #1 of 0.04 M 2.2.2-tribromoethanol (1 g/ml in iso-amyl al- 
cohol subsequently diluted 80x in PBS; Merck, Darmstadt, Ger- 
many). Thymectomy was performed by suction via a transcervical- 
retrosternal incision. Experiments were begun after the mice had 
rested for 7 d. 
Antibodies. The following antibodies were used in this study: 
anti-V~6 (44.22.1) (20), anti-V~8.2 (F23.2) (2), anti-V~14 (14.2) 
(21), anti-CD4 (GK1.5) (22), anti-CD8 (53-6.7) (23), and anti- 
Thy-1 (AT83) (24). 
Cell Preparations. Suspensions of CD4 + and CD8 + T cells 
were prepared from lymph node, and B cells were from spleen. 
CD4 + or CD8 § T cells were first positively selected (to >95% 
purity) using directly coupled anti-CD4 or anti-CD8 microbeads 
and a magnetic ell separation device (MACS| Mihenyi Biotec 
GmbH, Bergisch-Gladbach, Germany) (25). These cells were stained 
with fluorescently labeled (either FITC or PE) anti-CD4 or anti- 
CDS. B cells were enriched from spleen by anti-Thy-1 plus comple- 
ment treatment and stained with a polyclonal rabbit F(ab)2 
anti-mouse Ig FITC conjugate. These preparations were further 
purified to >99.5% homogeneity b  sorting using a FACStar Plus |
(Becton Dickinson & Co., Mountain View, CA). Peripheral blood 
was taken from the tail vein and mononuclear cells were isolated 
by centrifugation of heparinized samples (diluted with PBS-FCS) 
on a Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) cushion. 
Flow Cytometry. Lymph node cells or PBMC were labeled in 
a single step with direct FITC conjugates of either anti-V~6, anti- 
Va8.2, or anti-Va14, together with anti-CD4-PE (Becton Dick- 
inson & Co.). Monitoring of the levels of Va6* cells among 
CD4 + T cells in blood samples was controlled in each case by 
measurement of Va14 + cells in the same preparation. All samples 
were analyzed using a FACScan | and the Lysys II program (Becton 
Dickinson & Co.). Dead cells were excluded by a combination of 
forward and side scatter. 
Cell Transfers. Mice were injected in one hind footpad with the 
indicated numbers of purified cells in 25 #1 of PBS. Control mice 
were either not injected or received 25 #1 of PBS or syngeneic ceils. 
Results 
Local Va6 + CD4 + T Cell Response Induced by Transfer of 
Lymphocyte Subsets from Mice Expressing Endogenous Mtv-7 (Mls- 
I') or Infectious MMTV(SW). After injection of B cells 
from Mls-1 ~ congenic BALB/c mice (BALB.D2; Mtv-7 +, 
H-2 a) into the hind footpad of BALB/c (Mtv-7-) mice, we 
observed a strong and specific increase in the number of TCK- 
V~6 + CD4 + cells in the popliteal lymph node, which peaked 
between 3 and 5 d after injection. Given the dominance 
of TCK-Va6 + CD4 + cells relative to other Mls-P-reactive 
TCK-Va in responses to Mls-1 9 (26), we confined study of 
reactive cells to this population. The specifidty of the response 
was ensured by following the frequencies of cells expressing 
nonreactive TCK-Va domains (either V~8.2 or Val4). 
Around 25% of total CD4 + T cells expressed V~6 compared 
with ~11% in control mice (Table 1). This response was only 
induced by B cells and not by purified (>99.5% pure) 
CD4 + or CD8 + T cells from Mtv-7 § mice. Since a previous 
report (15) showed that CD8 + T cells were also able to in- 
duce proliferation in mice of the H-2 k haplotype (after in- 
travenous injection into thymectomized recipients), we in- 
jected either purified B cells or CD8 + T cells from CBA/J 
(Mtv-7 § , H-2 k) mice into the footpads of CBA/Ca (Mtv-7-, 
H-2 k) mice. Again, B cells efficiently stimulated a V~6 + 
CD4 + T cell response whereas CD8 + T cells did not (Ta- 
ble 1). 
Similarly, we analyzed the response of BALB/c mice to puri- 
fied B cells, CD8 + T cells, and CD4 + T cells from ~>6-mo- 
old BALB/c mice neonatally infected with MMTV(SW) (here- 
after referred to as BALB/c [SW]). Infection of donor mice 
was verified by the absence of TCIK-V~6 + cells in the pe- 
riphery before isolation of lymphocyte populations. In each 
case no proliferative response was detected (Table 1). 
Deletion of Va6 + CO4 + T Cells Induced by Transfer of Lym- 
phocyte Subsets from Mice Expressing Endogenous Mtv.7 or In- 
fectious MMTV(SW). In experiments conducted in parallel 
with the above stimulation studies, we monitored TCK- 
V~6 + CD4 + cells in the peripheral blood in recipient mice 
injected with the purified cell subsets. In all experiments, the 
specificity of deletion was verified by monitoring the levels 
of V~14 +CD4 + T cells. This control population remained 
largely unaffected in all experiments, except for slight, com- 
Pensatory increases in their percentage due to the deletion 
ofMtv-7-reactive T cells (data not shown). In agreement with 
a previous tudy (27), specific deletion of V~6§ * T cells 
in BALB/c mice was detected as early as 2 wk after injection 
of either B cells or CD8 § T cells but not CD4 + T cells 
from BALB.D2 Mtv-7 + mice (Fig. 1 A). Dose-response and 
kinetic studies demonstrated that the deletion of TCK- 
V~6 + CD4 + cells induced by injection of CD8 + T cells was 
slightly faster and of greater magnitude than that induced 
by the same number of B cells (Fig. 1, B and C). In all 
cases we observed continuous deletion over the entire time 
course (>160 d), suggesting persistence of Mtv-7 + cells in 
the recipients. 
Since the mouse strains used for these experiments were 
Mls-1 ~ congenic, it seemed likely that permanent chimerism 
was established in the relevant subsets. This hypothesis was 
tested in experiments where B calls, CD8 + T ceils, and 
CD4 + T ceils were purified from mice that had previously 
received B cells or CD8 + T cells from BALB.D2 mice, and 
transferred into new host BALB/c mice. In these secondary 
transfers, ddetion was only induced by the CD8 + T cell 
subset and not by any other subset from mice that had re- 
ceived CD8 + T cells in the primary transfer (Fig. 2 A). 
However, no subset (including B cells) from mice that had 
received BALB.D2 B cells originally was able to induce dele- 
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Table 1. In Vivo Response toCells from Mice Expressing Endogenous Mtv-7 (Mls-l*) or from Mice Maternally Infected with 
MMT"V(SW) 
CD4* T cell subset* 
Responder Donor Injected 
strain strain subset V~6 Va8.2 Val4 
BALB/c 
(Mls-1 b) 
CBA/CaH 
(MIs-1 b) 
BALB.D2 (Mls-P) B 23.5 _+ 3.8 11.6, 11.1 8.1 __ 0.2 
CD8 11.6 _+ 1.I 13.2 • 0.3 9.7 _+ 0.2 
CD4 13.5 + 2.7 12.6, 12.7 9.1 • 0.4 
BALB/c (SW) B 12.1, 11.9 13.4, 13.4 9.5, 9.9 
CD8 11.3, 12.0 13.6, 14.8 9.4, 9.1 
CD4 12A, 13.0 13.7, 14.0 9.4, 9.7 
BALB/c (Mls-1 b) B 11.9, 11.8 13.3, 12.8 10.0, 10.0 
CD8 11.3, 11.4 12.8, 14.0 9.8, 9.6 
CD4 11.9, 12.1 13.0, 13.0 9.9, 9.8 
No injection 11.5 • 0.6 13.4 + 0.4 9.8 • 0.3 
CBA/J (Mls-P) B 21.6, 27.4 ND 5.2, 5.0 
CD8 12.2, 12.7 ND 6.5, 6.5 
No injection 11.0 • 0.5 ND 6.8 • 0.2 
* Draining lymph node cells were taken 3-4 d after injection of 106 cells of the indicated subsets and assessed for the expression f the different 
TCR-Va domains by flow cytometry. Results from individual mice are presented, or are given as the mean _+ SD where three or more mice were 
independently examined. Significantly increased percentages areshown in boldface. 
tion upon retransfer (Fig. 2 B), even though deletion of TCR- 
V~6+CD4 + cells in the donor animals was stable and as 
complete as in the recipients of CD8 + T cells. 
In contrast o the results obtained using cells from an 
Mtv-7 + donor, each lymphocyte subset (including CD4 + 
T cells) from ~>6-mo-old BALB/c(SW) mice induced 
Va-specific T cell deletion upon transfer to noninfected con- 
trol mice (Fig. 3). Consistent with this, we confirmed 
MMTV(SW) infection in each subset using a PCR assay to 
detect he presence of viral DNA as previously described (28, 
and data not shown). Deletion was induced more efficiently 
by transfer of T cell subsets than by B cells. Furthermore, 
in secondary transfers each of the subsets was able to induce 
a similar degree of deletion regardless of the original subset 
transferred (Fig. 4). Thus, virus was transmitted from B cells 
to both CD4 + and CD8 + T cells, from CD8 + T cells to 
B cells and CD4 + T cells, and from CD4 + T cells to B cells 
and CD8 + T cells. It should be noted that the frequency of 
recipients in which deletion was observed after secondary 
transfer of the different subsets was higher for T cell recipients 
(greater for CD8 + than CD4 + T cells) than for B cell 
recipients, particularly if a lower cell number was injected 
in the secondary transfer (data not shown). 
Deletion of Reactive T Cells Occurs Both Intrathymically and 
in the Periphery. The deletion of peripheral T cells detected 
in the blood may have been a measure of ongoing intrathymic 
negative selection and thus dependent on homing of the in- 
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jected subsets to the thymus. Consistent with this, deletion 
of TCR-Va6 + cells was observed in the thymuses of 
BALB/c mice injected with BALB.D2 B cells or CD8 § T 
cells (data not shown). However, transfer of B cells or 
CD8 + T cells from either BALB.D2 or BALB/c(SW) mice 
into thymectomized BALB/c recipients induced eletion of 
TCR-Va6 + CD4 + cells, demonstrating extrathymic periph- 
eral T cell deletion (Fig. 5). 
Transfer of MMTV(SW)-infected Lymphocyte Subsets Leads 
to Mammary Gland Infection. Since MMTV is maternally 
transmitted, recipient BALB/c mice, in which deletion of 
TCR-V~6+CD4 § cells was observed after second-round 
transfer of infected lymphocyte subsets (described above), were 
bred with normal BALB/c males. Offspring were bled at 4-5 
wk of age and the levels of TCR-Va6 + CD4 + cells were fol- 
lowed to determine if milk transmission of MMTV(SW), 
and thus mammary gland infection, had occurred. In all the 
tested subset combinations ofprimary and secondary transfers, 
we observed ddetion of TCR-Va6§ § ceUs in pups 
demonstrating efficient infection of the mammary gland 
(Table 2). 
Discussion 
Previous work has suggested that superantigen-triggered 
deletion of mature T cells from the peripheral pool is associated 
with a prior expansion phase (15, 16, 29, 30). However, we 
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Figure 1. Kinetics of ddetion of V~6 + CD4 + T cells of BALB/c mice 
injected with BALB.D2.Mls-1 a cells. Blood samples were taken at the in- 
dicated time points after footpad injection. C A) Injection of 106 cells of 
each subset: B cells (O), CD8 + T cells (m), CD4 + T cells (l-]), or no 
injection (O). Each curve represents data from at least three mice (mean _+ 
SD). C B) Deletion dose response after injection of BALB.D2.MIs-1 a B cells: 
104 cells ( l l) ,  3 x 10 s cells ([~), 10 s cells (O), 3 x 10 4 cells (O), 10 4 
cells (A), no injection (A). Each curve represents data from two mice. 
(C) Deletion dose response after injection of BALB.D2.Mls-1 a CD8 + T 
cells: 10 6 cells ( I ) ,  3 x 10 s cells ([3), 10 0 cells (O), 3 x 104 cells (O), 
104 cells (A), or no injection CA). Each curve represents data from two 
mice. 
find that deletion of specific T cells can occur in the absence 
of detectable proliferation in at least three separate cases: (a) 
by injection of low doses of B cells from BALB.D2 mice; 
(b) by injection of BALB.D2 CD8 + T cells (even high 
doses); and (c) by injection of cells (B cells, CD4 + or CD8 + 
T cells) from BALB/c (SW) mice. Consistent with these ob- 
Figure 2. Kinetics of deletion of Vfl6+CD4 + T cells induced by sec- 
ondary transfer of lymphocyte subsets from some primary recipients of 
BALB.D2.Mls-1 a cells. B cells (O), CD8 + T cells ( , ) ,  and CD4 + T cells 
([~) were purified from mice in which Vfl6+CD4 + cells had been deleted 
after receiving either BALB.D2.Mls-1 a CD8 + T cells C A) or B cells (B). 
104 cells of each subset was transferred into secondary BALB/c recipients 
at >110 d after primary transfer. The levels of Vfl6+CD4 + T cells in pe- 
ripheral blood of the secondary recipients were monitored at the indicated 
time points. Each curve represents data from at least three mice (mean 
• SD). 
servations, significant cell cycling, as determined by measure- 
ment of DNA content, was only detectable among TCR- 
V~6+CD4 + cells when sufficient BALB.D2 B cells were 
injected (and not with either CD4 + or CD8 + T cells), 
whereas CD4 + T cells expressing TCR-V~14 + were not in- 
duced into cycle (our unpublished ata). Thus, our data sug- 
gest that encounter of reactive T cells with the superantigen 
from either the endogenous proviral Mtv-7 or the exogenous 
equivalent MMTV(SW) will eventually lead to deletion of 
T cells bearing the appropriate V~ domains, irrespective of 
whether proliferation occurs. Furthermore, they demonstrate 
that peripheral T cell deletion is a more sensitive process than 
peripheral T cell stimulation, as for intrathymic deletion 
(31-33), since it can occur in the absence of detectable ex- 
pansion. 
Our data indicate significant variation with respect to the 
ability of different cell types to present Mls-1 ~ in a form that 
is able to induce proliferation and/or deletion of the reactive 
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Figure 3. Kinetics of deletion ofV~6+CD4 +T cells of BALB/c mice 
injected with calls from BALB/c(SW) mice. Blood samples were taken at 
the indicated time points after footpad injection. Mice were injected with: 
106 B cells (Q), CD8 + T cells (R), CD4 + T cells (1-7), or no injection 
(O). Each curve represents data from two mice. 
V~6 + CD4 + T cells. An essential requirement for Mls-1 a pre- 
sentation would, logically, be the expression ofMtv -70RF  
transcripts, which were detectable in all subsets using a PCR- 
based strategy (28, and our unpublished ata). Clearly, con- 
stitutive xpression of class II MHC is also required for the 
induction of proliferation of the ORF-reactive T cells since 
B cells but neither CD4 + nor CD8 + T cells (both gener- 
ally accepted to be class II MHC negative in the mouse), 
were able to stimulate a classical Mls-1 ' response after 
transfer. However, the factors determining the capacity of 
a given cell type to present Mls-1 ~ for the induction of pe- 
ripheral clonal deletion are much less clear. Consistent with 
a previous report (27), both B cells and CD8 + T cells in- 
duced deletion, while similar doses of CD4 + T cells did not. 
In considering this unexpected dichotomy between CD4 + 
and CD8 + T ceUs, it is conceivable that an MHC class II- 
negative cell expressing Mtv-7 can induce deletion by first 
transferring ORF products to an MHC class II-positive cell. 
Such transfers of molecules from CD8 + T cells have in fact 
been reported in other systems, i.e., for the lysosomal en- 
zymes Cr and ~-glucuronidase (34, 35). In the 
case of ORF products this may require transfer of only small 
amounts of the antigen since deletion is a more sensitive 
readout han proliferation (31-33), which may explain the 
failure to detect ransfer previously in one (36) but not in 
other reports (37, 38). Alternatively, it is possible that the 
injected CD8 + T ceUs passively acquire class II MHC mob 
ecules (39) more efficiently than CD4 + cells, enabling them 
to directly present ORF product o reactive T cells. A final 
consideration for the putative transfer of ORF products is 
that it would probably require continuous exposure to ORF 
molecules, since B cells from a mouse that received CD8 + 
T cells (BALB.D2.Mls-1 a) did not stably acquire the Mtv-7 + 
phenotype and induce deletion upon retransfer. 
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Figure 4. Kinetics of deletion of VO6 + CD4 + T cells induced by sec- 
ondary transfer of lymphocyte subsets from primary recipients of cells from 
BALB/c(SW) mice. B cells (O), CD8 + T cells ( I ) ,  and CD4 + T cells 
([]), were purified from mice in which V~6+CD4 +cells had been deleted 
after receiving either BALB/c(SW) B cells (A), CD8 + T cells (B), or 
CD4 + T cells (C). 106 cells of each subset were transferred into secondary 
BALB/c recipients at ~70 d after primary transfer. The levels of 
V~6 + CD4 + T cells in peripheral blood of the secondary recipients were 
monitored at the indicated time points. Each curve represents data from 
two to four mice (mean _+ SD). 
The greater deletion-inducing capacity of CD8 + T cells 
relative to B cells from Mls-l"-expressing mice raises the pos- 
sibility that CD8 + T cells may proliferate or survive better 
than B cells after transfer to the host animal. This point is 
supported by the secondary subset ransfers in which only 
CD8 + T cells were able to induce deletion of TCR- 
Vo6+CD4 + cells. Therefore, the inability of B cells to in- 
duce deletion after a second-round transfer may have been 
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Peripheral deletion of V~6 + CD4 + T cells induced by injec- 
IS .  
tion of BALB.D2.Mls-1 acells or cells from BALB/c(SW) mice. Recipients 
were thymectomized I wk before injection of the indicated subsets. Deletion 
profiles of mice injected with 106 B cells (@) or CD8 + T cells (Is) from 
BALB.D2.MIs-1 ~ mice, or B cells (O) or CD8 + T cells (l-q) from 
BALB/c(SW) mice, or mice that were not injected (&). Each curve 
represents data from two mice. 
dependent on the degree of B cell chimerism established in 
the original recipients. Differences in the efficiency of chi- 
mera formation between B cells and CD8 + T cells could 
theoretically be due to the recognition of a small number 
of minor histocompatibility differences between BALB/c and 
BALB.D2 mice that have been shown to lead to BALB.D2 
anti-BALB/c cytotoxic T cell responses (40). It is conceiv- 
able that such a response among the BALB.D2 CD8 + T 
ceils would result in their proliferation, whereas B cells would 
presumably he unaffected. Inexperiments where BALB/c mice 
were injected with either B cells or CD8 + T cells from 
(BALB/c x BALB.D2)F1 mice (Mls-1 ~ and tolerant to 
BALB/c minor antigens), both cell types from the F1 donors 
induced eletion of TCR-Va6 + CD4 + cells. However, only 
the CD8 + T cell subset aken from primary recipients of F1 
CD8 § T cells was able to induce deletion upon secondary 
transfer, demonstrating that the establishment of chimerism 
in the CD8 + T cell compartment did not require activation 
of the donor cells by minor histocompatibility antigens (our 
unpublished observations). Interestingly, comparison of the 
deletion kinetics induced by the F1 subsets relative to 
BALB.D2 subsets indicated that the F1 CD8 + T cells (but 
not the F1 B cells) were less efficient than their parental 
counterparts, suggesting that the capacity to induce deletion 
may nevertheless have been enhanced by responses to minor 
histocompatibility antigens (our unpublished observations). 
Each of the MMTV(SW)-infected subsets was able to act 
as a source of infectious virus that could be transmitted to
the other lymphocyte subsets and ultimately to the mam- 
mary gland. This is consistent with a previous report showing 
T cell-dependent expression of viral gp52 by mammary gland 
after transfer of lymphoid ceils from MMTV(C3H)-infected 
mice (18). Interestingly, virus transmission between subsets 
was slightly less efficient from B cell to B cell, judging by 
the lower frequency of second-round B cell recipients in which 
deletion occurred. Whether the efficiency of transmission from 
one subset o another varies due to different virus receptors 
Table  2. Mammary Gland Infection (Milk Transmission) f MMTV(SW) Induced by Transfer of Lymphocyte Subsets from 
Maternally Infected Mice 
Secondary BALB/c recipient (mother) 
Offspring 
CD4 + T cells CD4 § T cells 
Primary subset Secondary subset 
transfer* transfer* V~6 V~14 V~6 Vf114 
B B 1.8 11.2 6.0 _+ 1.7 9.5 +_ 0.5 
CD8 1.7 10.5 4.3 +_ 0.9 8.9 _+ 0.2 
CD4 1.8 11.1 ND ND 
CD8 B 1.2 12.2 2.6 +_ 0.4 9.8 _+ 0.5 
CD8 1.4 10.5 6.0 _+ 0.9 8.6 + 0.5 
CD4 1.0 11.2 3.7 _+ 0.8 10.3 +_ 0.3 
CD4 B 2.2 12.0 5.9 _+ 1.2 8.5 +_ 0.8 
CD8 1.4 11.3 6.2 _+ 0.8 9.3 +_ 0.5 
CD4 2.1 10,7 3.3 _+ 0.8 9.7 _+ 0,4 
Normal BALB/c (no transfers) 10.2 _+ 0.6 9.9 _+ 0.7 
* Primary subset donors were BALB/c (SW) mice. 
* Donors for the secondary subset ransfers were the BALB/c recipients of the primary transfers. These mice were mated with normal (uninfected) 
BALB/c males. Offspring from these pairs were bled at 4-6 wk of age. The percentages of V~6 § and V~14 + T cells in the CD4 + T cell subset 
in peripheral blood were determined by flow cytometry. Data are given as mean _+ SD of four pups from each litter. 
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on different cell types, to the percentage ofvirus-infected cells 
in each subset at the time of transfer, or to the characteristics 
of the interactions between the subsets can not be determined 
using this approach. With respect o the latter, the lower 
efficiency of virus transfer from injected B cells to host B 
cells may reflect infrequent B-B interactions (as compared with 
T-B interactions) during which direct virus transfer could 
take place and/or the requirement for an intermediate virus 
host (e.g., T cells) for infection of B cells of the recipient 
animal. Additionally, the dependence ofvirus transfer on cell- 
to-cell contact is consistent with the observation that viremia 
is generally not associated with infection by MMTV and that 
MMTV can not be transferred by plasma (41). Indeed, using 
the most sensitive readout known for MMTV infection (i.e., 
T cell deletion) we have similarly failed to see any evidence 
for transmission of MMTV(SW) after transfer of plasma or 
cell-free culture supernatants from infected mice (our unpub- 
lished observations). These data argue against ransfer of free 
MMTV particles in the cell injections described here. 
The kinetics of infection of the different lymphocyte subsets 
in maternally infected mice were not addressed in this study 
(all maternally infected animals were used as donors at i>6 
mo of age). However, from the subset ransfer experiments 
we know that detectable transmission of virus from one lyre- 
phocyte subset o another can take place within at least 10 
wk (earlier time points were not tested), but this may vary 
depending on the subset in question. The spread of the virus 
away from the site of infection (i.e., to the mammary gland 
and other peripheral lymphoid organs) via migration of in- 
fected cells must occur rapidly since deletion of peripheral 
TCR-V~6 + CD4 + cells can be detected as soon as 4 wk after 
birth or 2 wk after cell transfers. Furthermore, the breeding 
of second-round recipients indicated that virus transmission 
to the mammary gland could occur within 14 wk after transfer 
of the infected subsets, and probably more rapidly since mater- 
nally infected females of 8-9 wk of age can transmit virus 
to their first litter at this time (data not shown). We have 
recently obtained results demonstrating viral DNA in B cells 
but not T cells of draining lymph nodes in adult mice 6 d 
after virus injection, suggesting that these cells are the pri- 
mary targets for viral infection (28). The events that follow 
to bring about infection of other subsets are currently being 
assessed todetermine the pathways taken by the virus to achieve 
mammary gland infection. The mode of infection of the mam- 
mary gland of the adult recipients, either directly by the trans- 
ferred infected subset or via an intermediate cell type, and 
the requirement for superantigen-induced T cell responses 
in this transmission require further investigation. 
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